Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer of Ethyl 3-[3-Amino-4-(Methylamino)-N-(2-Pyridyl)benzamido]propionate (CAS: 212322-56-0) with high quality, intermediate of Dabigatran Etexilate (CAS: 211915-06-9). Ruifu Chemical can provide worldwide delivery, competitive price, excellent service, small and bulk quantities available. Purchase Dabigatran Etexilate Intermediates, Please contact: alvin@ruifuchem.com
| Chemical Name |
Ethyl 3-[3-Amino-4-(Methylamino)-N-(2-Pyridyl)benzamido]propionate |
| Synonyms |
Dabigatran Intermediate 1; 3-[3-Amino-4-(Methylamino)-N-(2-Pyridyl)benzamido]propionic Acid Ethyl Ester; Ethyl 3-[[3-Amino-4-(Methylamino)benzoyl](Pyridin-2-yl)amino]propionate; N-[3-Amino-4-(Methylamino)Benzoyl]-N-2-Pyridinyl-Beta-Alanine Ethyl Ester; Dabigatran Impurity 37; Dabigatran Impurity P; Dabigatran Methylamino Impurity |
| Stock Status |
In Stock, Commercial Production |
| CAS Number |
212322-56-0 |
| Molecular Formula |
C18H22N4O3 |
| Molecular Weight |
342.40 g/mol |
| Melting Point |
100.0 to 106.0℃ |
| Density |
1.261±0.06 g/cm3 |
| Sensitive |
Heat Sensitive |
| Solubility |
Soluble in Methanol |
| COA & MSDS |
Available |
| Sample |
Available |
| Product Categories |
Intermediate of Dabigatran Etexilate |
| Origin |
Shanghai, China |
| Brand |
Ruifu Chemical |
| Items |
Specifications |
Results |
| Appearance |
Off-White or Pale Yellow Crystalline Powder |
Off-White Crystalline Powder |
| Melting Point |
100.0~106.0℃ |
101.0~102.0℃ |
| Loss on Drying |
<0.50% |
0.10% |
| 4-Aminobenzonitrile |
<1.00% |
0.12% |
| Purity / Analysis Method |
>99.0% (HPLC) |
99.75% |
| Infrared Spectrum |
Consistent with Structure |
Complies |
| 1H NMR Spectrum |
Consistent with Structure |
Complies |
| Conclusion |
The product has been tested and complies with the given specifications |
| Application |
Intermediate of Dabigatran Etexilate (CAS: 211915-06-9) |
Package: Fluorinated Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement.
Storage Condition: Keep the container tightly closed and store in a cool, dry and well-ventilated warehouse away from incompatible substances. Protect from light and moisture.
Shipping: Deliver to worldwide by air, by FedEx / DHL Express. Provide fast and reliable delivery.
| Glacia Acetic Acid |
CH3COOH |
CAS 64-19-7 |
| Dichloromethane |
CH2Cl2 |
CAS 75-09-2 |
| Ethyl Acetate |
C4H8O2 |
CAS 141-78-6 |
| Mobile Phase |
Buffer Solution (0.025mol/L KH2PO4, pH=3.1):Acetonitrile=60:40 |
| Column |
Kromasil 100-5 C18 250*4.6mm*5μm |
| Dilute |
Water:Acetonitrile=50:50 |
| Flow |
1.0mL/min |
| Column Temperature |
25℃ |
| Run Time |
30min |
| Wavelength |
254nm |
| Injection Volume |
10μL |
How to Purchase? Please contact Dr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience? We have more than 15 years of experience in the manufacture and export of a wide range of high quality pharmaceutical intermediates or fine chemicals.
Main Markets? Sell to domestic market, North America, Europe, India, Korea, Japanese, Australia, etc.
Advantages? Superior quality, affordable price, professional services and technical support, fast delivery.
Quality Assurance? Strict quality control system. Professional equipment for analysis include NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, K.F, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc.
Samples? Most products provide free samples for quality evaluation, shipping cost should be paid by customers.
Factory Audit? Factory audit welcome. Please make an appointment in advance.
MOQ? No MOQ. Small order is acceptable.
Delivery Time? If within stock, three days delivery guaranteed.
Transportation? By Express (FedEx, DHL), by Air, by Sea.
Documents? After sales service: COA, MOA, ROS, MSDS, etc. can be provided.
Custom Synthesis? Can provide custom synthesis services to best fit your research needs.
Payment Terms? Proforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
Ethyl 3-[3-Amino-4-(Methylamino)-N-(2-Pyridyl)benzamido]propionate (CAS: 212322-56-0), intermediate of Dabigatran Etexilate (CAS: 211915-06-9). Dabigatran Etexilate is the newest generation of oral anticoagulant drugs – direct thrombin inhibitors (DTIs), belonging to non-peptide thrombin inhibitors and instead specifically and selectively blocks the thrombin activity (free or bound) to prevent coagulation. Dabigatran targets the preventative and clinical treatment needs of acute and chronic thromboembolic disease. Compared to the control group treated with Warfarin, Dabigatran can significantly decrease the risk of stroke and embolic disease (including hemorrhagic stroke), greatly reduce the occurrence of bleeding (including fatal bleeding and intracranial hemorrhage), and greatly lower vascular mortality rate. Dabigatran provides effective and stable anticoagulant effects and does not require constant monitoring of anticoagulant functions or dosage adjustments.
